scholarly article | Q13442814 |
P356 | DOI | 10.1002/PDS.943 |
P8608 | Fatcat ID | release_yikjv6gdujek5hoyzblvxbs22i |
P698 | PubMed publication ID | 15133780 |
P50 | author | Kenneth Rothman | Q25190000 |
P2093 | author name string | Kenneth J Rothman | |
P433 | issue | 5 | |
P921 | main subject | bias | Q742736 |
P304 | page(s) | 295-298 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
P1476 | title | A potential bias in safety evaluation during open-label extensions of randomized clinical trials | |
P478 | volume | 13 |
Q41677049 | Assessing bias: the importance of considering confounding |
Q57786004 | Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease |
Q43854731 | Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials |
Q42439105 | Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial. |
Search more.